| 000 -LEADER |
|---|
| fixed length control field |
00607nam a22002177a 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20160607105142.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
160607b xxu||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9241545593 (pbk) |
| 040 ## - CATALOGING SOURCE |
|---|
| Transcribing agency |
UG |
| 050 ## - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RM301 .56 |
| Item number |
W5 |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
WHO model formulary 2002/ editors Mary R. Couper, Dinesh K. Mehta.- |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc |
Geneva, Switzerland: |
| Name of publisher, distributor, etc |
WHO, |
| Date of publication, distribution, etc |
2000. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
vi, 517p. |
| 600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Couper, Mary R. |
|
|---|
| Personal name |
Mehta, Dinesha K |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Drug, activation |
|
|---|
| Topical term or geographic name as entry element |
Essential drugs |
|
|---|
| Topical term or geographic name as entry element |
Biological products |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Entry Department |
HSRC |
| Source of classification or shelving scheme |
|
| Verified |
O.H |